Showing results (21-30 of 93) with videos related to

Sort By:
Pageof 10
Discover Oncology|February 24, 2022
The impact of endogenous estrogen exposures on the characteristics and outcomes of estrogen receptor positive, early breast cancerYasmin Korzets, Orly Yariv, Raz Mutai, et al.
Breast Cancer Research and Treatment|December 17, 2008
Does multicentric/multifocal breast cancer differ from unifocal breast cancer? An analysis of survival and contralateral breast cancer incidenceRinat Yerushalmi, Hagen Kennecke, Ryan Woods, et al.
Cancer Treatment Reviews|October 31, 2020
National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional studyTal Etan, Eitan Amir, Ariadna Tibau, et al.
Harefuah|January 25, 2022
[RAPIDLY PROGRESSING PARAPARESIS AND LOSS OF SENSATION BELOW T10 DURING NEOADJUVANT CHEMOTHERAPY FOR BREAST CANCER]Orly Yariv, Alexandra Benouaich-Amiel, Tanseem Kab, et al.
Breast Care (Basel, Switzerland)|December 7, 2016
Invasive Lobular Carcinoma of the Breast: Appearance on Digital Breast TomosynthesisAhuva Grubstein, Yael Rapson, Sara Morgenstern, et al.
BMC Cancer|February 16, 2024
Central nervous system metastases in breast cancer patients with germline BRCA pathogenic variants compared to non-carriers: a matched-pair analysisMatan Ben-Zion Berliner, Shlomit Yust-Katz, Inbar Lavie, et al.
The Israel Medical Association Journal : IMAJ|October 25, 2006
Endobronchial stent for malignant airway obstructionsRinat Yerushalmi, Eyal Fenig, David Shitrit, et al.
Breast Cancer Research and Treatment|June 4, 2020
Evolution in the risk of adverse events of adjuvant endocrine therapy in postmenopausal women with early-stage breast cancerDaniel Reinhorn, Rinat Yerushalmi, Assaf Moore, et al.
Oncology|June 28, 2014
The 21-gene recurrence score assay (Oncotype DX™) in estrogen receptor-positive male breast cancer: experience in an Israeli cohortTal Grenader, Rinat Yerushalmi, Margarita Tokar, et al.
Acta Oncologica (Stockholm, Sweden)|September 14, 2007
Daily low-dose/continuous capecitabine combined with neo-adjuvant irradiation reduces VEGF and PDGF-BB levels in rectal carcinoma patientsDavid Loven, Einat Be'ery, Rinat Yerushalmi, et al.
Pageof 10